| Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study AF Daly, MA Tichomirowa, P Petrossians, E Heliovaara, ML Jaffrain-Rea, ... The Journal of Clinical Endocrinology & Metabolism 95 (11), E373-E383, 2010 | 395 | 2010 |
| Patient-specific dosimetry in predicting renal toxicity with 90Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose–effect relationship R Barone, F Borson-Chazot, R Valkema, S Walrand, F Chauvin, L Gogou, ... Journal of nuclear medicine 46 (1 suppl), 99S-106S, 2005 | 391 | 2005 |
| Risk factors and causes of death in MEN1 disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) cohort study among 758 patients P Goudet, A Murat, C Binquet, C Cardot-Bauters, A Costa, P Ruszniewski, ... World journal of surgery 34, 249-255, 2010 | 384 | 2010 |
| 90Y-edotreotide for metastatic carcinoid refractory to octreotide DL Bushnell Jr, TM O'Dorisio, MS O'Dorisio, Y Menda, RJ Hicks, ... Journal of Clinical Oncology 28 (10), 1652, 2010 | 382 | 2010 |
| ARMC5 Mutations in Macronodular Adrenal Hyperplasia with Cushing's Syndrome G Assié, R Libé, S Espiard, M Rizk-Rabin, A Guimier, W Luscap, ... New England Journal of Medicine 369 (22), 2105-2114, 2013 | 364 | 2013 |
| Clinical characterization of familial isolated pituitary adenomas AF Daly, ML Jaffrain-Rea, A Ciccarelli, H Valdes-Socin, V Rohmer, ... The Journal of Clinical Endocrinology & Metabolism 91 (9), 3316-3323, 2006 | 289 | 2006 |
| EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds F Giammarile, L Bodei, C Chiesa, G Flux, F Forrer, F Kraeber-Bodere, ... European journal of nuclear medicine and molecular imaging 38, 1393-1406, 2011 | 277 | 2011 |
| Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients M Schlumberger, A Hitzel, ME Toubert, C Corone, F Troalen, ... The Journal of Clinical Endocrinology & Metabolism 92 (7), 2487-2495, 2007 | 267 | 2007 |
| Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients M Brassard, I Borget, A Edet-Sanson, AL Giraudet, O Mundler, M Toubeau, ... The Journal of Clinical Endocrinology & Metabolism 96 (5), 1352-1359, 2011 | 250 | 2011 |
| Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience G Raverot, N Sturm, F de Fraipont, M Muller, S Salenave, P Caron, ... The Journal of Clinical Endocrinology & Metabolism 95 (10), 4592-4599, 2010 | 250 | 2010 |
| Interest of Chromogranin A for diagnosis and follow‐up of endocrine tumours D Nehar, C Lombard‐Bohas, S Olivieri, B Claustrat, JA Chayvialle, ... Clinical endocrinology 60 (5), 644-652, 2004 | 239 | 2004 |
| Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study R Libe, I Borget, CL Ronchi, B Zaggia, M Kroiss, T Kerkhofs, J Bertherat, ... Annals of Oncology 26 (10), 2119-2125, 2015 | 233 | 2015 |
| Practical dosimetry of peptide receptor radionuclide therapy with 90Y-labeled somatostatin analogs S Pauwels, R Barone, S Walrand, F Borson-Chazot, R Valkema, LK Kvols, ... Journal of nuclear medicine 46 (1 suppl), 92S-98S, 2005 | 233 | 2005 |
| Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry S Fieffe, I Morange, P Petrossians, P Chanson, V Rohmer, C Cortet, ... European journal of endocrinology 164 (6), 877-884, 2011 | 208 | 2011 |
| Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients L Vroonen, ML Jaffrain-Rea, P Petrossians, G Tamagno, P Chanson, ... European journal of endocrinology 167 (5), 651-662, 2012 | 205 | 2012 |
| Spontaneous fertility and pregnancy outcomes amongst 480 women with Turner syndrome V Bernard, B Donadille, D Zenaty, C Courtillot, S Salenave, ... Human Reproduction 31 (4), 782-788, 2016 | 201 | 2016 |
| MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs Endocrines P Goudet, A Dalac, M Le Bras, C Cardot-Bauters, P Niccoli, ... The Journal of Clinical Endocrinology & Metabolism 100 (4), 1568-1577, 2015 | 193 | 2015 |
| Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency F Borson-Chazot, A Serusclat, Y Kalfallah, X Ducottet, G Sassolas, ... The Journal of Clinical Endocrinology & Metabolism 84 (4), 1329-1333, 1999 | 177 | 1999 |
| Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry L Maione, T Brue, A Beckers, B Delemer, P Petrossians, F Borson-Chazot, ... European Journal of Endocrinology 176 (5), 645-655, 2017 | 172 | 2017 |
| Predicting visual outcome after treatment of pituitary adenomas with optical coherence tomography M Jacob, G Raverot, E Jouanneau, F Borson-Chazot, G Perrin, ... American journal of ophthalmology 147 (1), 64-70. e2, 2009 | 169 | 2009 |
